Vaccine Info

GEO-LM01 Lassa Fever Vaccine

Description

GEO-LM01 is a vaccine candidate that is based on the Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform, which generates noninfectious VLPs in the individual being vaccinated.

VLPs mimic a natural infection, triggering the body to produce a robust and durable immune response with both antibodies and T cells.

Indication

GEO-LM01 is indicated to prevent Lassa Fever Infection

Dosage

This vaccine candidate has only been tested in mice.

Updated
September 5th, 2019